Cyclafem 1/35 and Central nervous system leukaemia - from FDA reports


Summary

There is no Central nervous system leukaemia reported by people who take Cyclafem 1/35 yet. This review analyzes which people have Central nervous system leukaemia with Cyclafem 1/35. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Cyclafem 1/35 and have Central nervous system leukaemia, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Cyclafem 1/35 and have Central nervous system leukaemia

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Mar, 25, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Central nervous system leukaemia when taking Cyclafem 1/35?

Cyclafem 1/35

Cyclafem 1/35 has active ingredients of ethinyl estradiol; norethindrone. It is often used in birth control. (latest outcomes from Cyclafem 1/35 135 users)

Central Nervous System Leukaemia

Central nervous system leukaemia (cancer of central nervous system) has been reported by people with acute lymphocytic leukemia (all), chronic myeloid leukaemia, acute myeloid leukaemia, acute promyelocytic leukaemia, acute lymphocytic leukaemia recurrent (latest reports from 63 Central nervous system leukaemia patients).

Browse all side effects of Cyclafem 1/35

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Central nervous system leukaemia

Central nervous system leukaemia

Could your condition cause Central nervous system leukaemia

Central nervous system leukaemia

Related studies